Azithromycin

Description

Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation.

Medicine classification

J01FA10

Azithromycin

J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides

S01AA26

Azithromycin

S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics

Medicines

ARATRO

Spain

AZADOSE

France

AZASITE

United States

AZIBACT

Hong Kong

AZIBIOT

Lithuania

AZICINE

Hong Kong

AZIMAX

Hong Kong Singapore

AZIN

Hong Kong

AZINIX

Hong Kong

AZISTRO

Austria

AZITHMAX

Hong Kong

AZITHRAN

Cyprus

AZITHROCIN

Hong Kong

AZITROX

Lithuania

AZMYCIN

Singapore

AZTRIN

Hong Kong

AZYDROP

Spain

AZYTER

Austria Cyprus France Hong Kong Netherlands

BEZANIN

Cyprus

BINOZYT

Hong Kong Singapore

CLINDAL

Hong Kong

EUZIMAX

Hong Kong

FLOCTIL

Hong Kong

IMEXA

Hong Kong Singapore

MARZOMAX

Hong Kong

NIFOMAX

Hong Kong

ORDIPHA

France

RAZIMAX

Cyprus

SUMAMED

Hong Kong Lithuania

ZAROM

Hong Kong

ZATHRIN

Hong Kong

ZEDBAC

United Kingdom

ZEDD

Australia

ZETRO

Hong Kong

ZIMAX

Hong Kong

ZINFECT

Cyprus

ZITHRIN

Hong Kong

ZITHRO

Australia

ZITHROMAX

Australia Austria Canada Cyprus France

ZITHROTEL

Cyprus Hong Kong

ZITROMAX

Spain

ZMAX

Lithuania Singapore

ZYCIN

Hong Kong

ZYLUMIT

Lithuania

Product monographs

ZITHROMAX Capsule, hard

MPI, EU: SmPC

ZELBAC Powder for solution for infusion

MPI, EU: SmPC

Usage: Next >

Azithromycin

Description

Medicine classification

Medicines

Product monographs

2D Molecule Structure

3D Molecule Structure

Unique Ingredient Identifier (UNII)

CAS Registry Number

SNOMED-CT